Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05712408
Other study ID # IRB-21-629
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date April 19, 2023

Study information

Verified date August 2023
Source University of North Texas, Denton, TX
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The current study aims to test an online, non-restrictive diet among persons with multiple sclerosis (MS). Diet is the number one searched second-line therapy among persons with MS, however there are currently no established dietary approaches to improve health and wellbeing among persons with MS. Participants will complete the 8-week diet program using an online application. The primary research question is whether the diet program is acceptable and can improve general health indicators including cholesterol, glucose, body weight, body fat as well as MS symptoms (i.e., walking, cognition, fatigue, and quality of life).


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date April 19, 2023
Est. primary completion date April 19, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - age 18-70 years - a self-reported diagnosis of multiple sclerosis - relapse free in past 30 days - non-pregnant - willing and able to visit University of North Texas on two testing occasions Exclusion Criteria: - electronic medical implant, such as a heart pacemaker or an implantable cardioverter defibrillator (ICD)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
800g Challenge
The intervention will involve 8 weeks of an online diet program. Outcomes testing will occur at baseline and post-intervention (following 8 week diet program). During the first 4 weeks, participants will receive educaitonal material and log their daily points in an online application and attend a weekly check-in call with members of the research team. During weeks 5-8, participants will log their daily points in the online application.

Locations

Country Name City State
United States University of North Texas Denton Texas

Sponsors (1)

Lead Sponsor Collaborator
University of North Texas, Denton, TX

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Acceptability of Intervention Participants ratings of satisfaction with the diet program. Scores range from 1-5 with higher scores indicating greater satisfaction. From recruitment to end of 8 week intervention
Primary Metabolic Health Fasted Cholesterol and Gloucose From recruitment to end of 8 week intervention
Primary Body Weight Change in Body Weight From recruitment to end of 8 week intervention
Primary Body Fat Change in Body Fat Percentage From recruitment to end of 8 week intervention
Secondary 6-Minute Walk Change in 6-Minute Walk Distance From recruitment to end of 8 week intervention
Secondary 25-Foot Walk Change in 25-Foot Walk Speed From recruitment to end of 8 week intervention
Secondary Cognitive Assessments Change in the Brief International Cognitive Assessment in MS Scores. Scores range from 0-208 with higher scores indicating greater cognitive functioning. From recruitment to end of 8 week intervention
Secondary Fatigue Change in Fatigue Severity Scale Scores. Scores range from 1-7 with higher scores indicating greater fatigue. From recruitment to end of 8 week intervention
Secondary Health-Related Quality of Life Change in SF-12 Scores. Scores range from 0-100 with higher scores indicating greater health-related quality of life. From recruitment to end of 8 week intervention
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4